Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(25%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_4
2
17%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (16.7%)
N/A10 (83.3%)

Trials by Status

completed542%
recruiting325%
unknown433%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12